Blood–brain barrier (BBB) is a natural protective membrane that prevents central nervous
system (CNS) from toxins and pathogens in blood. However, the presence of BBB …

The present review sets out to discuss recent developments of the effects and mechanisms
of carrier properties on their circulation time. For most drugs, sufficient in vivo circulation time …

Inspired by natural biology, cell membrane-mimetic surface engineering and cell membrane
camouflaging technology have been widely investigated. Notably, the cell membrane …

Nanoparticles (NPs) modified by cell membranes represent an emerging biomimetic
platform that can mimic the innate biological functions resulting from the various cell …

The invention of silica-based bioactive glass in the late 1960s has sparked significant
interest in exploring a wide range of silicon-containing biomaterials from the macroscale to …

Synthetic nanoparticles are extensively utilized in various biomedical engineering fields
because of their unique physicochemical properties. However, their exogenous …

The blood–brain barrier (BBB) acts as a physical/biochemical barrier that protects brain
parenchyma from potential hazards exerted by different xenobiotics found in the systemic …

In the last decades, many nanovectors were developed for different diagnostic or therapeutic
purposes. However, most nanosystems have been designed using a “bottom-up” approach …

Nanotechnology has revolutionized cancer drug delivery, and recent research continues to
focus on the development of “one-size-fits-all,” ie,“all-in-one” delivery nanovehicles …

Nanotechnology-based drug delivery platforms have been developed over the last two
decades because of their favorable features in terms of improved drug bioavailability and …